5. References

  1. IBM Micromedex® DRUGDEX® (electronic version). IBM Watson Health, Greenwood Village, Colorado, USA. Available at: https://www-micromedexsolutions-com.libproxy.uthscsa.edu/ (cited: June 14, 2023).
  2. Clinical Pharmacology [database online]. Tampa, FL: Gold Standard, Inc.; 2023. Available at: http://clinicalpharmacology-ip.com.ezproxy.lib.utexas.edu/. Accessed June 14, 2023.
  3. Montelukast (Singulair®) package insert. Organon LLC, June 2021.
  4. Zafirlukast (Accolate®) package insert. Strides Pharma Science Limited, December 2022.
  5. U.S. Department of Health and Human Services. National Institutes of Health. National Heart, Lung and Blood Institute. National Asthma Education and Prevention Program. Expert Panel 3: guidelines for the diagnosis and management of asthma. Full report 2007. NIH Publication No. 08-4051. Accessed June 14, 2023.
  6. National Heart, Lung, and Blood Institute. 2020 focused updates to the asthma management guidelines: a report from the national asthma education and prevention program coordinating committee expert panel working group. National Institutes of Health. December 2020. Accessed June 14, 2023. 
  7. Global Initiative for Asthma. Global strategy for asthma management and prevention. Updated 2022. Available at: https://ginasthma.org/gina-reports/. Accessed June 14, 2023.
  8. Zileuton extended release oral tablets package insert. Rising Pharmaceuticals, Inc., March 2023.